CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves

[ad_1] Cold and flu medicine including NyQuil sit on a store shelf in Miami on Sept. 12, 2023. Joe Raedle | Getty Images CVS is removing some of the most…

Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge

[ad_1] Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, and lifted its full-year guidance as sales in the company’s pharmaceutical and medical devices…

Birkenstock expects to price IPO at $46 per share, toward midpoint of stated range

[ad_1] Birkenstock models stand in a retail store of the shoe manufacturer. The company plans to go public in New York.  Sebastian Christoph Gollnow | Picture Alliance | Getty Images…

After Birkenstock’s ‘Barbie’ bump, iconic footwear brand seeks a big part in IPO market

[ad_1] The Birkenstock IPO is drawing attention for the company’s recent growth under LVMH-affiliated private equity investor L Catterton’s control. The brand received an extra push from its recent role…

Decongestant found in many cold, allergy medicines doesn’t actually work, FDA advisors say

[ad_1] Cold and flu medicine including Nyquil sits on a store shelf on September 12, 2023 in Miami, Florida. Joe Raedle | Getty Images The main ingredient used in many…

J&J’s consumer-health spinoff Kenvue jumps 22% in public market debut

[ad_1] Shares of Johnson & Johnson‘s consumer-health spinoff Kenvue jumped 22% Thursday after its market debut on the New York Stock Exchange, making it the biggest U.S. IPO in more…

J&J’s consumer-health spinoff Kenvue jumps 20% in public market debut

[ad_1] Johnson & Johnson’s consumer-health spinoff Kenvue started trading on the New York Stock Exchange under the stock ticker KVUE. At its opening price of $25.53, Kenvue had an implied…

J&J’s consumer health business Kenvue is going public this week. Here’s what to know

[ad_1] Johnson & Johnson products on a shelf in a store in New York. Lucas Jackson | Reuters Johnson & Johnson‘s consumer health business, Kenvue, is expected to go public…